Approval · Notice of Compliance 17587 · 2015
ESOMEPRAZOLE: Notice of Compliance 17587
Issued December 17, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17587
- Date
- December 17, 2015
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ESOMEPRAZOLE | 02449587 | Cancelled Pre Market |
| ESOMEPRAZOLE | 02449595 | Cancelled Pre Market |
Medicinal ingredients
- ESOMEPRAZOLE 20 MG per TAB
- ESOMEPRAZOLE 40 MG per TAB